SynthesisCardiovascular diabetology2021

Effects of sodium-glucose cotransporter type 2 inhibitors on cardiovascular, renal, and safety outcomes in patients with cardiovascular disease: a meta-analysis of randomized controlled trials.

Caiyun Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.